Dachaigh › Gnìomhan › Medical Scientists, Except Epidemiologists › Lexington, MA
Medical Scientists, Except Epidemiologists ann an Lexington, MA: Tuarastalan H-1B
37 iarrtasan cumhaichean-obrach airson an dreuchd seo le làrach-obrach ann an Lexington, MA. Tuarastal bunasach meadhanach $141,084; leth meadhanach $117,714–$158,945.
A rèir ìre tuarastail
| Ìre tuarastail | Tuarastal meadhanach |
|---|---|
| Ìre I (innte) | $132,500 |
| Ìre II (càileachail) | $110,000 |
| Ìre III (eòlach) | $135,462 |
| Ìre IV (gu lèir comasach) | $159,317 |
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Luchd-fastaidh
| Neach-obrach | LCAs | Tuarastal meadhanach |
|---|---|---|
| Takeda Development Center Americas, Inc. | 11 | $140,000 |
| SalioGen Therapeutics Inc. | 4 | $99,460 |
| Takeda Pharmaceuticals USA, Inc. | 3 | $150,000 |
| Voyager Therapeutics, Inc. | 3 | $159,771 |
| Cystic Fibrosis Foundation | 3 | $143,000 |
| Keros Therapeutics | 2 | $106,500 |
| Novo Nordisk Research & Development US, Inc. | 2 | $154,942 |
| Takeda Pharmaceuticals America Inc. | 2 | $164,480 |
| General Hospital Corporation | 1 | $110,000 |
| Agenus Inc. | 1 | $110,000 |
| Fosun Pharma USA, Inc. | 1 | $95,400 |
| Curis, Inc. | 1 | $205,000 |
| Dicerna Pharmaceuticals, Inc. | 1 | $150,000 |
| KSQ Therapeutics, Inc. | 1 | $158,882 |
| Bicycle Therapeutics, Inc. | 1 | $135,000 |
Tiotalan dreuchd
- Scientist I3
- Scientist3
- Senior Scientist I3
- Senior Research Associate2
- Sr. Staff Engineer CMC2
- Scientist II2
- Medical Science Liaison2
- Researcher1
- Senior Clinical Trials Associate Manager1
- Scientist, In Vivo1
- Translational Medicine Scientist, Clinical Development1
- Associate Scientific Director1
- Scientist CMC1
- Associate Scientist1
- Associate Director Clinical Sciences1
Luchd-taic H-1B ann an Lexington, MA →
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).